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The effect that multiple percutaneous exposures to Schistosoma larvae has on the development of early CD4 lymphocyte reac-
tivity is unclear, yet it is important in the context of humans living in areas where schistosomiasis is endemic. In a murine model
of multiple infections, we show that exposure of mice to repeated doses (4) of Schistosoma mansoni cercariae, compared to a
single dose (1), results in CD4 T cell hyporesponsiveness within the skin-draining lymph nodes (sdLN), manifested as re-
duced CD4 cell proliferation and cytokine production. FoxP3 CD4 regulatory T cells were present in similar numbers in the
sdLN of 4 and 1mice and thus are unlikely to have a role in effecting hyporesponsiveness. Moreover, anergy of the CD4 cell
population from 4mice was slight, as proliferation was only partly circumvented through the in vitro addition of exogenous
interleukin-2 (IL-2), and the in vivo blockade of the regulatory molecule PD1 had a minimal effect on restoring responsiveness.
In contrast, IL-10 was observed to be critical in mediating hyporesponsiveness, as CD4 cells from the sdLN of 4mice deficient
for IL-10 were readily able to proliferate, unlike those from 4wild-type cohorts. CD4 cells from the sdLN of 4mice exhib-
ited higher levels of apoptosis and cell death, but in the absence of IL-10, there was significantly less cell death. Combined, our
data show that IL-10 is a key factor in the development of CD4 T cell hyporesponsiveness after repeated parasite exposure in-
volving CD4 cell apoptosis.
Schistosomiasis is a disease caused by parasitic helminths ofSchistosoma sp. and affects230 million people worldwide (1,
2), with a further 779 million people at risk of infection (3, 4). In
regions of endemicity, individuals are liable to be repeatedly ex-
posed to free-swimming infective Schistosoma cercariae, resulting
in multiple infections. Consequently, analyses of human immune
responses to schistosomes are likely to be based upon individuals
who have been exposed to multiple doses of excretory/secretory
(E/S) material released by infectious larvae as well as other life
cycle stages (e.g., eggs). Individuals with chronic schistosomiasis
tend to develop a downregulated adaptive immune response (e.g.,
see references 5–7), which may be due to repeated exposure to
infective larvae and/or long-term exposure to adult worms and
eggs. In the former situation, infective cercariae release abundant
E/S material originating from the glycocalyx and acetabular glands
(8), which have immune-downregulatory activity (9–12). Indeed,
whole-blood cultures from infected individuals from an area in
northern Senegal where schistosomiasis is endemic secrete larger
quantities of regulatory interleukin-10 (IL-10) in response to cer-
carial E/S material than do those from uninfected individuals (13).
However, it is not known to what extent immune downregulation
is caused by repeated exposure to infective cercariae and their E/S
antigens.
In order to investigate the development of innate and acquired
immune responses following repeated exposure to infective cer-
cariae prior to the onset of egg deposition from adult worms, we
developed a murine model of multiple schistosome infections
(14). We reported that multiple exposures (4) of the skin to
infective schistosome cercariae resulted in CD4 T cells in the
skin-draining lymph nodes (sdLN) becoming hyporesponsive to
antigen stimulation, in terms of their ability to proliferate and
secrete cytokines, which developed before the presence of eggs in
the hepatic portal system (14). The hyporesponsive state was sys-
temic and led to a subsequent downmodulation of granulomatous
immunopathology to eggs in the liver (14). Clearly, repeated ex-
posure of the host to schistosome cercariae has an immunomodu-
latory effect, independent of egg deposition, but the mecha-
nism(s) that underpins CD4 T cell hyporesponsiveness induced
by repeated exposure to schistosome larvae is not known.
CD4 cell hyporesponsiveness caused by parasitic infections
(15–17), particularly of Th2 lymphocytes due to chronic helminth
infection, is well established (18–20). Typically, it manifests as an
inability of antigen-specific cells to proliferate upon antigen re-
stimulation and a failure to release specific cytokines (e.g., gamma
interferon [IFN-] and IL-5). Various mechanisms of hypore-
sponsiveness have been proposed, including those intrinsic to the
antigen-specific CD4 lymphocyte population (e.g., anergy, ex-
haustion, or apoptosis) as well as extrinsic factors (e.g., inhibition
by FoxP3 CD4 regulatory T [Treg] cells or regulatory IL-10).
The lack of responsiveness by antigen-specific CD4 lymphocytes
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has traditionally been referred to as anergy when the cells are re-
challenged with antigen but in the absence of positive costimula-
tion, e.g., via CD28 (21, 22). Exhaustion of CD8 and CD4 lym-
phocytes has been described following exposure to persistent/
chronic infection with viruses (23) as well as several parasitic
protozoa (17), especially where the host is exposed to a high anti-
genic load. These mechanisms are associated with various coin-
hibitory receptors, such as programmed cell death 1 (PD1) (24).
Another aspect that could contribute to hyporesponsiveness is the
induction of activation-induced cell death (AICD) or apoptosis in
the T cell population, particularly through the engagement of Fas/
FasL (25, 26). The importance of anergy, exhaustion, and/or
AICD in the development of CD4 cell hyporesponsiveness fol-
lowing repeated exposure to infective schistosome larvae is un-
known, but others have suggested that CD11bmacrophages act-
ing as antigen-presenting cells (APCs) are modulated by prepatent
schistosome worms (27). Finally, while extrinsic mechanisms of
CD4 cell hyporesponsiveness, such as CD4Treg cells (28–30) or
regulatory IL-10 (31–33), have been explored in the context of
chronic schistosome infection (i.e., in the presence of eggs), they
have not been investigated following repeated exposure to schis-
tosome larvae prior to the production of eggs.
Here, we conducted a closer examination of the immune re-
sponses in the sdLN of mice exposed to 4 versus 1 doses of
Schistosoma mansoni cercariae, in order to determine the relative
contributions of the different mechanisms mentioned above that
may result in CD4 T cell hyporesponsiveness. We show that
CD4 T cells from 4 mice displayed a greater propensity to
become anergic and were more likely to enter apoptosis, resulting
in increased numbers of dead cells. We conclude that the early
development of CD4 T cell hyporesponsiveness in the host is
dependent primarily upon the presence of regulatory IL-10 de-
rived from CD4 cells in the sdLN induced by repeated exposure
to infectious schistosome larvae.
MATERIALS AND METHODS
Animals.Wild-type (WT) C57BL/6 and IL-10-deficient (knockout [KO])
mice (34), transgenic mice expressing an Ab-restricted ovalbumin peptide
(pOVA)-reactive T cell receptor (TCR) on a RAG/ background (OT-
II) (35), and IL-10 reporter knock-in (tiger) mice (36) were bred and
housed at the University of York. Female mice aged between 6 and 10
weeks were used for all experiments, which were carried out in accordance
with the United Kingdom Animals Scientific Procedures Act 1986 and
with approval of the University of York Ethics Committee.
Infection protocol and parasites. The life cycle of a Puerto Rican
strain of S. mansoni was maintained at the University of York by routine
passage through outbred NMRI mice and Biomphalaria glabrata snails.
Mice used for experiments were percutaneously exposed via each pinna to
multiple doses (4) of 150 S. mansoni cercariae at weekly intervals from
day 0 to day 21, as previously described (14, 37). Age- and sex-matched
cohorts were exposed in parallel to a single dose (1) of 150 cercariae on
day 21. By using this infection protocol, via the pinna, a 50% penetration
rate is observed (37), amounting to 75 cercariae per pinna, or 150 cercar-
iae per mouse, at each time point. In order to control for the infection
dose, in some experiments, 1 mice were exposed to either a single low
dose (150 cercariae) or a single high dose (600 cercariae). In all experi-
ments, auricular lymph nodes draining the skin site of infection (sdLN)
were harvested 4 days after infection or, in selected experiments for 1
mice, 25 days after infection [yielding the infection group 1 (d25)].
In vitro culture of total sdLN cells. A soluble schistosomula antigen
preparation (SSAP) was prepared from in vitro-cultured, mechanically
transformed larvae, as described previously (38), in order to stimulate
sdLN cells for an antigen-specific recall response (37). Single-cell suspen-
sions from the sdLN were cultured at 1  106 cells/ml in RPMI 1640
medium containing 10% heat-inactivated fetal calf serum (FCS) (Bios-
era), 2 mM L-glutamine, 50 U/ml penicillin, 50 g/ml streptomycin, and
50 M 2-mercaptoethanol (all from Gibco) in the presence or absence of
50 g/ml SSAP for 72 h at 37°C. Proliferation was measured either by
[3H]thymidine incorporation (18.5 kBq per well) (39) or after labeling
with 3M carboxyfluorescein diacetate succinimidyl ester (CFSE) (Invit-
rogen) (14). In the latter situation, cells were subsequently labeled with an
anti-CD4 monoclonal antibody (MAb), and proliferation was deter-
mined by flow cytometry, judged according to the decrease in the fluores-
cence of CFSE.
Cytokine analysis by ELISA. Culture supernatants were collected
from the in vitro sdLN cell cultures at 72 h for cytokine analysis, as de-
scribed previously (40). The amounts of IL-4 were determined by using
DuoSet enzyme-linked immunosorbent assay (ELISA) kits (R&D Sys-
tems). Amounts of IFN- were measured by using capture and detection
antibodies (BD Pharmingen).
In vivo cell proliferation. In vivo cell proliferation was determined by
bromodeoxyuridine (BrdU) incorporation. Mice received 1 mg BrdU
(Sigma) intraperitoneally (i.p.) daily for the final 4 days before harvest of
the sdLN. The sdLN cells were then processed to a single-cell suspension
and blocked with anti-CD16/32 MAbs (eBioscience) in goat serum
(Sigma) and later surface stained for anti-CD3 eF450 and anti-CD4 phy-
coerythrin (PE)-Cy7 (both from eBioscience) in phosphate-buffered sa-
line (PBS) supplemented with 1% FCS. Subsequently, cells were washed in
PBS–1% FCS and incubated in 1 Fixation/Permeabilization buffer
(eBioscience) for at least 1 h at 4°C. Cells were then washed in PBS–1%
FCS and incubated at 37°C in 100 g DNase (Sigma) for 1 h. Afterwards,
cells were washed in PBS–1% FCS and stained for 45 min at room tem-
perature with anti-BrdU allophycocyanin or rat IgG1 allophycocyanin
(eBioscience) in 1 permeabilization buffer, according to the manufac-
turer’s protocol.
Flow cytometry. Cells were incubated with anti-CD16/32 MAbs
(eBioscience) in goat serum (Sigma) to block the nonspecific uptake of
antibodies and then subsequently labeled with the following MAbs con-
jugated to fluorescent labels: anti-CD4, anti-CD3, anti-CD8, anti-B220,
anti-CD25, anti-CD103, anti-PD1, anti-PDL-1, anti-PDL-2 PE, anti-Fas,
anti-FasL, anti-CD69, anti-CD44, anti-CD62L, anti-major histocompat-
ibility complex class II (MHC-II) (IA-IE), anti-Nrp1, anti-CD11b (all
from eBioscience), anti-CD49b (BioLegend), and anti-LAG3 (CD223)
(BD Bioscience). Intracellular staining was performed according to the
manufacturer’s protocol for anti-FoxP3, anti-Helios, and anti-cytotox-
ic-T lymphocyte-associated antigen 4 (CTLA-4) (eBioscience). All flow
cytometry data were acquired by using the Cyan ADP analyzer or the BD
LSR Fortessa analyzer. Flow data were analyzed by using FlowJo software
v7.6.5 (Tree Star, Inc.) or Summit v4.3 (DakoCytomation).
Blockade of PD1. In some experiments, the expression of PD1 was
blocked through the use of an anti-PD1 antibody (RMP1-14) (BioXCell).
Repeatedly infected mice (4mice) received 500 g i.p. in a 200-l vol-
ume weekly, 1 day before each infection time point. The singly infected
mice (1mice) received one dose of 500 g i.p. 1 day prior to infection.
Control mice received 200 l PBS i.p.
Annexin V assay. Cells were stained for the cell surface markers CD3
and CD4 as described above. Subsequently, the cells were washed in cold
PBS supplemented with 1 cold annexin V binding buffer (eBioscience)
and were then incubated for 15 min with anti-annexin V fluorescein iso-
thiocyanate (FITC) at room temperature and finally washed in annexin V
binding buffer. Cells were then resuspended in annexin V binding buffer
for analysis, and propidium iodide (PI) (eBioscience) was added directly
before acquiring data on the Cyan ADP analyzer.
CD4 cell sorting and in vitro coculture with antigen-presenting
cells. Cells from the sdLN of 1 and 4 WT and IL-10-deficient mice
were prepared as a single-cell suspension and labeled with antibodies
against CD45, CD3, CD4, and B220, as described above. The cells were
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then sorted into CD45 CD3 CD4 T cells and CD45 CD3 CD4
B220 APC populations by using a fluorescence-activated cell sorter
(FACS) (MoFlo Astrios; Beckman Coulter). The CD3CD4T cells were
labeled with 3 M CFSE (Invitrogen), as described above, and then stim-
ulated with 50 g/ml SSAP for 72 h as cocultures of T cells (5 104 cells)
and APCs (1 104 cells) in combinations from different groups of mice.
Antigen-specific proliferation was measured by a decrease in the expres-
sion of CFSE after 72 h, as described above.
Real-time quantitative PCR.Cells from the sdLN were washed in cold
PBS, resuspended in TRIzol (Invitrogen), and stored at 80°C. Total
RNA was extracted, cDNA was generated by using Superscript II DNA
polymerase (Invitrogen), and real-time quantitative PCR (qRT-PCR) was
performed by using the StepOne Plus system (Applied Biosystems) with
SYBR green (Applied Biosystems). The expression levels of genes were
determined relative to the level of the housekeeping gene glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) by using theCT method. Prim-
ers used were GAPDH forward primer CCATGTTTGTGATGGGTGTG,
GAPDH reverse primer CCTTCCACAATGCCAAAGTT, Fas forward
primer CTACTGCGATTCTCCTGGCT, Fas reverse primer GGTTCCAT
GTTCACACGAGG, FasL forward primer CTCCGTGAGTTCACCAA
CCA, and FasL reverse primer TAAATGGGCCACACTCCTCG.
Statistics. Statistical analyses were performed by using Student’s t test,
the Mann-Whitney U test, one-way analysis of variance (ANOVA), or a
Kruskal-Wallis test. GraphPad Prism v5 software was used to perform the
statistical analyses (GraphPad Software, Inc.).
RESULTS
CD4 T cell hyporesponsiveness in sdLN is due to repeated ex-
posures to S. mansoni cercariae. The proliferation of in vitro-
cultured total sdLN cells in response to soluble larval parasite an-
tigen (SSAP) was increased in cells recovered from both 1 and
2mice 4 days after the final infection (Fig. 1A). However, after
four exposures (4) to S. mansoni cercariae, total sdLN cells from
4mice exhibited significantly lower levels of proliferation (P	
0.001) (Fig. 1A). Hyporesponsiveness was evident in the CD4 T
cell population, as CD4 T cells from 4mice divided to a much
lesser extent than did CD4 T cells from 1 mice (P 	 0.001)
(Fig. 1B), and was not simply confined to cell proliferation, as
IFN- and IL-4 cytokine production from antigen-stimulated in
vitro-cultured cells was also significantly reduced in 4 compared
to 1mice (P	 0.05) (Fig. 1C and D). Moreover, although CD4
cells from 1mice harvested on day 25 (cf. day 4) also exhibited
low levels of proliferation (P 
 0.05) (cf. 4 or naive cells) (Fig.
1B), this reflects the disappearance of antigen-specific cells in the
absence of further antigen stimulation in vivo rather than the de-
velopment of hyporesponsiveness, as 1 (d25) CD4 cells re-
leased substantial amounts of IFN- in response to parasite anti-
gen (P	 0.01) (Fig. 1C).
Hyporesponsiveness was specific to parasite antigen, since
sdLN cells from uninfected OT-II mice (in which CD4 T cells
express a TCR specific to the OVA323–339 peptide) and those ex-
posed to either 1 or 4 doses of schistosome cercariae all had
similar highly elevated levels of in vitro proliferation in response to
OVA peptide (Fig. 1E). Furthermore, hyporesponsiveness was not
dependent on the number of parasites used at infection, since the
proportion of proliferating CD4 cells from mice exposed to a
single low dose of cercariae was not significantly different from
that from mice exposed to a single high dose equivalent to the
cumulative dose experienced by 4 mice (P 
 0.05) (Fig. 1F).
Cells from mice exposed to either a low or high dose of cercariae
also secreted large quantities of IFN- and IL-4 (see Fig. S1A and
S1B in the supplemental material), showing that the infection
dose is not a factor in the induction of lymphocyte hyporespon-
siveness.
Infection with S. mansoni increases lymphocyte cellularity
of sdLN. The total numbers of cells recovered from the sdLN of
both 1 and 4 mice 4 days after the last infection were signifi-
cantly increased compared to those of the naive group (Fig. 2A).
Conversely, the number of sdLN cells from 1mice obtained 25
days after infection was low and not significantly different from
that of the naive group (P 
 0.05) (Fig. 2A). The proportions of
cells that were CD4 in the sdLN of 1 and 4mice were much
lower than those in naive mice (P	 0.05) (Fig. 2B) but not signif-
icantly different between the two groups of infected mice. The
FIG 1 Lymphocyte hyporesponsiveness in sdLN is due to repeated exposure
to S. mansoni cercariae. Mice were exposed to one (1), two (2), or four
(4) doses of 150 cercariae via percutaneous infection of the pinna at 7-day
intervals, and sdLN were recovered 4 days after the final exposure. (A) Prolif-
eration of sdLN cells from 1, 2, or 4 versus naive mice stimulated with
SSAP in vitro prior to determination of proliferation, measured by the uptake
of [3H]thymidine (cpm in the presence of SSAP minus cpm in medium only).
(B) Proliferation of sdLN cells as a proportion of CFSEdim CD4 cells cultured
in vitro in the presence or absence of SSAP. Groups shown are naive (Nai), 1,
4, and 1 (d25) mice. Ag, antigen. (C and D) Detection of IFN- (C) and
IL-4 (D) secreted by in vitro-cultured sdLN cells in response to SSAP stimula-
tion, as measured by cytokine-specific ELISAs. The horizontal dotted line rep-
resents the minimum level of detection. (E) Proliferation of sdLN cells from
schistosome-infected transgenic OT-II mice stimulated with medium or
ovalbumin peptide. (F) Proliferation of CD4 cells from mice exposed to a
single low dose (150 cercariae) or a high dose (600 cercariae), shown as a
proportion of CFSEdim CD4 cells following restimulation in vitro in the pres-
ence or absence of SSAP. Statistical significance was determined by using the
Mann-Whitney U test (, P 	 0.05; , P 	 0.01; , P 	 0.001; n.s., not
significant). Data are representative of results from 2 to 5 independent exper-
iments (n 4 to 6 mice).
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FIG 2 The proportion of FoxP3 regulatory T cells does not change between 1 and 4mice. (A and B) Total cell numbers from the sdLN (A) and proportion
of sdLN CD4 cells (B), as determined by flow cytometry. (C) Representative flow cytometry dot plots showing the gating strategy for FoxP3 and CD25CD4
sdLN cells from naive, 1, and 4mice obtained 4 days after infection, previously gated on CD4 T cells. (D) FoxP3 CD4 Treg cells as a proportion of total
CD4 cells. The means and standard errors of the means for groups of naive, 1, and 4 mice (n  5) are shown. (E and F) Expression of CD103 (E) and
CTLA-4 FoxP3CD4 (F) cells. Symbols are percent expression values for individual mice (n 4 or 5); horizontal bars represent the means standard errors
of the means. (G) Representative flow cytometry dot plots for CD4 cells labeled with anti-Nrp1 and anti-Helios antibodies. Values in the upper right quadrant
represent the proportions of thymic Nrp1 Helios CD4 cells in the sdLN from 1 and 4mice. (H) Nrp1 Helios CD4 Treg cells as a proportion of total
CD4 cells. Means and standard errors of the means for groups of 1 and 4 mice (n  5) are shown. Statistical significance was determined by using the
Mann-Whitney U test (n.s., P
 0.05; , P	 0.05; , P	 0.01; , P	 0.001).
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proportions of CD8 and B220 cells also did not differ between
1 and 4mice (P
 0.05) (see Fig. S1C and S1D in the supple-
mental material), indicating that exposure to repeated doses ver-
sus a single dose of cercariae does not have a major effect upon the
different types of lymphocytes found in the sdLN. In both groups
of infected mice, B cells probably account for most of the increased
sdLN cellularity compared to naive animals.
Theproportionof FoxP3 regulatoryT cells doesnot change
between 1 and 4 mice. An increase in the proportion of
FoxP3 regulatory T (Treg) cells could account for the hypore-
sponsive state observed in CD4 cells from 4 compared to 1
mice. However, the proportions of FoxP3 CD25 Treg cells in
sdLN were similar in 1 and 4mice (P
 0.05) (Fig. 2C and D).
In addition, the expression levels of CD103 (integrin E7),
which provides an indication of the functional status of FoxP3
Treg cells (41, 42), were equivalent in FoxP3
 cells from naive, 1,
and 4mice (Fig. 2E), as were the expression levels of intracellu-
lar CTLA-4, thought to be crucial for the function and suppressive
ability of FoxP3 Treg cells (43) (Fig. 2F). Thymic FoxP3
 Treg
cells can be differentiated from peripheral FoxP3 Treg cells
through their expression of neuropilin 1 (Nrp1) and the transcrip-
tion factor Helios (44, 45). Nevertheless, the proportions of He-
liosNrp1CD4 thymic Treg cells also did not differ between the
sdLN of 1 and 4mice (P
 0.05) (Fig. 2G and H), and there-
fore, together, our data do not support a role for increased num-
bers of FoxP3 Treg cells in the sdLN of 4 mice as the cause of
CD4 lymphocyte hyporesponsiveness.
A proportion of CD4 cells from 4 mice are anergic. In
order to investigate whether anergy was a cause of hyporespon-
siveness, sdLN cells from infected mice were cultured in vitro in
the presence of parasite antigen, with or without the addition of
exogenous recombinant IL-2. While CD4 T cells from 1mice
proliferated strongly in response to SSAP, the level of proliferation
was not further enhanced by the addition of IL-2 (Fig. 3A). On the
other hand, CD4 T cells from 4 mice, which hardly prolifer-
ated, were partly rescued from their hyporesponsive state follow-
ing the addition of exogenous IL-2 in vitro compared to the anti-
gen alone (P	 0.05) (Fig. 3A), although the addition of IL-2 did
not restore proliferation to the levels recorded for antigen-stimu-
lated cells from 1mice (P	 0.001) (Fig. 3A).
Anergic cells are known to exhibit increased expression levels
of programmed cell death marker 1 (PD1) and its ligands (PDL-1
and PDL-2) on a number of different cell types (46, 47). Indeed,
the expression level of PD1 was increased on CD4 cells from 4
compared to 1mice (P	 0.05) (Fig. 3B), as was the expression
level of PDL-1 (P	 0.05) (Fig. 3C). However, although the PDL-2
expression level was increased on CD4 cells from 4 compared
to naive mice (P	 0.05), it was not increased above the expression
level in 1 mice (P 
 0.05) (Fig. 3D). Expression levels of PD1
and PDL-1 on CD11b myeloid cells were not significantly in-
creased in 4 compared to 1mice (P
 0.05) (see Fig. S2A and
S2B in the supplemental material), although the PDL-2 level was
significantly higher on 4 than on 1 sdLN CD11b cells (P 	
0.05) (see Fig. S2C in the supplemental material).
In order to determine if PD1 was required in vivo for the de-
velopment of hyporesponsiveness, mice were administered anti-
PD1 MAb throughout the infection process, and the proliferation
of CD4T cells was determined in vivo by the uptake of BrdU (Fig.
3E). There was no difference in the numbers or proportions of
CD4 sdLN cells in mice after the PD1 blockade (data not shown).
However, the proliferation of CD4 cells of 4mice following the
blockade of PD1 signaling was marginally increased compared to
that of 4 control mice (P	 0.05) (Fig. 3F). Conversely, the PD1
blockade had no effect on the proliferative capacity of CD4 cells
from 1mice (Fig. 3F).
CD4 T cells from 4mice exhibit increased levels of apop-
tosis.Expression levels of Fas (CD95) and FasL (CD178), as mark-
ers of future cell death (48), were significantly increased on CD4
T cells from the sdLN of 4 compared to 1 and naive mice (P	
0.05) (Fig. 4A and B), indicating that the engagement of Fas with
FasL could facilitate elevated levels of AICD in the sdLN of 4
mice in response to repeated schistosome infection. Analysis of
CD4 cells according to positive staining for propidium iodide
(PI) and annexin V (Fig. 4C) revealed that the proportion of an-
nexin V-positive (annexin V) PI-negative (PI) apoptotic cells
was highest in 4mice, as was the proportion of annexin V PI
dead cells (both P	 0.05) (Fig. 4D). This was reflected by a cor-
responding decrease in the proportion of viable annexin V PI
CD4 lymphocytes in 4 mice (P 	 0.05) (Fig. 4D). Therefore,
repeated infection with schistosome larvae leads to a significant
increase in the proportion of apoptotic and dead CD4 cells,
which would affect the overall number of cells that can divide and
secrete cytokines.
Hyporesponsiveness in the CD4 lymphocyte population is
dependent upon the presence of IL-10. IL-10 is considered to be
a master regulator of the immune response (reviewed in reference
49; 50, 51); therefore, we sought to determine whether it was an
overriding factor in the development of CD4 hyporesponsive-
ness. Using IL-10 reporter mice (36), the overall proportion of
IL-10/green fluorescent protein-positive (GFP) cells obtained
directly ex vivo from the sdLN of infected mice in the absence of
stimulation with parasite antigen, or phorbol myristate acetate
(PMA), was low (Fig. 5A), although the proportion of IL-10/GFP
cells in 4mice was 10-fold higher than that in 1mice (P	 0.001)
(Fig. 5B). The majority (95%) of IL-10/GFP cells from the sdLN
were CD3CD4 T helper cells in both 4 and 1mice, with only
a small percentage being CD3 CD4 (probably CD8 cells) or
CD3 CD4 (which could be B cells or myeloid cells) (Fig. 5C).
However, there was no difference in the proportion of IL-10-produc-
ing FoxP3CD4Treg cells or in the proportion of IL-10-producing
Tr1 cells (LAG3CD49b) in 4 compared to 1mice (P
 0.05)
(Fig. 5D), although there was a reduction in the proportion of IL-10/
GFP Nrp1 Helios thymic Treg cells (P 	 0.05). Significantly,
there were more IL-10/GFP CD4 T cells of a nonregulatory phe-
notype (i.e., neither FoxP3Treg nor Tr1 cells) in 4 than in 1mice
(P	 0.001) (Fig. 5D).
The increased presence of IL-10/GFP cells in 4mice led us
to determine the contribution of IL-10 in causing immune hypo-
responsiveness in the sdLN of mice genetically deficient for IL-10.
Measurement of BrdU in vivo uptake demonstrated that the pro-
portions of proliferating CD4 cells were similar in 1 WT and
1 IL-10 KO mice (Fig. 5E and F). However, while the proportion
of dividing cells in vivo was, as expected, significantly reduced in
4 WT mice compared to 1 WT mice (P	 0.01), the propor-
tion of dividing CD4 cells in 4 KO mice was significantly
higher than that in 4WT mice and also higher than that in 1
KO mice (both P 	 0.05) (Fig. 5F). The absence of hyporespon-
siveness in 4 KO mice was further demonstrated in vitro, as
CD4 T cells from 4 KO mice proliferated in response to anti-
gen restimulation to a much greater extent than did those from
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4 WT mice (P 	 0.01) (Fig. 5G). In addition, the amounts of
IFN- secreted by sdLN cells from 4 KO mice were 100-fold
larger than the amounts secreted by cells from 4WT mice (P	
0.001) (Fig. 5H); the level of production of IL-4 was also higher in
the sdLN of 4KO mice (P	 0.05) (Fig. 5I). Consequently, in the
absence of IL-10, CD4 cells proliferate more vigorously than do
cells from WT mice and have an enhanced ability to secrete both
Th1 and Th2 cytokines, showing that IL-10 is essential for the
development of the observed hyporesponsiveness. Moreover, the
proportions of peripheral FoxP3 Treg, Nrp1
 Helios thymic
Treg, or LAG3
 CD49b Tr1 cells in the absence of IL-10 (i.e.,
between 4WT and 4KO mice) were not significantly different
(data not shown), supporting our above-described observations
which showed a lack of evidence for conventional CD4 Treg cells
as a cause of hyporesponsiveness in our infection model.
As IL-10 conventionally downregulates the activation status of
cells with antigen-presenting function (50), putative APCs from
IL-10 KO sdLN could be functionally more efficient at driving
CD4 cell proliferation. However, while the proliferation of
CD4 cells from 1WT sdLN was supported by putative endog-
enous APC populations recovered from the sdLN of 1WT, 4
WT, and 4KO mice, CD4 cells from the sdLN of 4WT mice
exhibited lower levels of proliferation upon coculture with APCs
from 1WT, 4WT, and 4KO mice (P	 0.001) (see Fig. S3 in
the supplemental material).
Absence of IL-10 in 4 mice leads to enhanced CD4 cell
activation and a decline in apoptosis. In the sdLN, there was a
significantly increased number of cells in 4 KO compared to
4 WT mice (P	 0.01) (Fig. 6A). The expression levels of the
activation markers CD69 and CD44 on CD4 T cells in the
FIG 3 Anergy in CD4 T cells from 4 mice. (A) Cells from sdLN of naive, 1, and 4 mice were cultured in vitro and stimulated with medium, SSAP,
exogenous IL-2 only, or SSAP and IL-2 combined. The proliferation of CD4 cells is shown as a proportion of CFSEdim CD4 cells. rIL-2, recombinant IL-2. (B
to D) Expression of PD1 (B), PDL-1 (C), and PDL-2 (C) on CD4 cells in sdLN from naive, 1, and 4mice, expressed as a proportion of total CD4 cells.
Symbols are percent expression values for individual mice; horizontal bars represent means standard errors of the means (n 4 mice). (E) Representative flow
cytometry dot plots showing expression of BrdU versus CD4, previously gated on CD4T cells. The gated population denotes those cells that are both CD4 and
BrdU. Cells from the sdLN were obtained from 1 and 4 mice given either regular injections of anti-PD1 antibody or control injections. (F) Graphical
representation of data acquired (as described above for panel E) from groups of 4 individual mice, shown as the percentage of CD4 BrdU cells. Symbols are
percent expression values for individual mice; horizontal bars represent means  standard errors of the means (n  4 mice). Statistical significance was
determined by using the Mann-Whitney U test (n.s., not significant; , P	 0.05). Data are representative of results from 1 to 3 independent experiments.
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sdLN were also significantly higher in 4 KO mice (both P 	
0.05) (Fig. 6B and C), while the proportion of CD62Llo CD4 T
cells was significantly increased (P 	 0.01) (Fig. 6D). Con-
versely, there were no significant differences in the expression
levels of PD1 and PDL-2 between 4 WT and KO mice, al-
though the level of PDL-1 was marginally higher in KO mice
(data not shown). Analysis of mRNA transcripts showed that
while there was a significant decrease in Fas expression the
FIG4 CD4T cells from 4mice exhibit increased levels of apoptosis. (A) Representative flow cytograms showing the expression of Fas and FasL on CD4 cells
from sdLN. Solid gray histograms show positive labeling with specific antibodies, while open histograms represent labeling with the isotype control antibody. (B)
Expression of Fas and FasL on CD4 cells in sdLN, expressed as a proportion of total CD4 cells. Symbols are percent expression values for individual mice;
horizontal bars represent means standard errors of the means (n 4 mice). (C) Representative flow cytometry dot plots showing the expression of annexin
V (Av) versus PI on CD4 T cells, where annexin V PI cells are apoptotic, annexin V PI cells are dead, and annexin V PI cells are live, from the sdLN of
naive, 1, or 4mice. (D) Data from groups of mice are presented as bars representing the means and standard errors of the means for separate groups of mice
(n  4). Statistical significance was determined by using the Mann-Whitney U test (, P 	 0.05). Data are representative of results from 3 independent
experiments.
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sdLN obtained from 4 KO mice (P	 0.05) (Fig. 6E), indicat-
ing that there was less apoptosis in the absence of IL-10, there
was no difference in the expression of FasL (P
 0.05) (Fig. 6E).
Moreover, although there were no significant differences in the
expression of these markers by flow cytometry for 4 KO com-
pared to 4 WT mice (P 
 0.05) (Fig. 6F), there was a trend
toward decreased expression in KO mice.
CD4 T cells in the sdLN of 4 WT compared to KO mice
exhibited high levels of apoptosis and death (both P	 0.05) (Fig. 6G
and H), which could account for the hyporesponsiveness ob-
served for the WT CD4 cell populations. Conversely, there was a
significantly higher proportion of live/viable CD4 T cells in the
sdLN of 4KO mice (P	 0.05) (Fig. 6H). Therefore, the presence
of IL-10 has a bearing on the levels of apoptosis and cell death,
FIG 5 CD4 cell hyporesponsiveness in sdLN is dependent upon IL-10. (A) Expression of IL-10 by sdLN cells from 1 and 4 IL-10 reporter knock-in (tiger)
mice compared to 1 WT mice, shown as representative flow cytometry dot plots of all cells gated on GFP cells. (B) Bar chart showing the percentage of
GFP/IL-10 cells as a proportion of all sdLN cells. (C) Bar chart showing GFP/IL-10 cells from 1 and 4mice plotted according to their expression of CD3
and CD4. Values given are percentages of CD3 CD4, CD3 CD4, and CD3 CD4 cells. (D) Proportion of IL-10/GFP CD4 cells, characterized as also
being FoxP3 (thymic and peripheral Treg cells), Nrp1
Helios (thymic Treg cells), LAG3
CD49b (Tr1 cells), or FoxP3Helios (nonregulatory cells). Bars
represent means and standard errors of the means for groups of 1 and 4 mice (n  5). (E) Number of cells that were dividing (i.e., BrdU), as shown by
representative flow cytometry dot plots for each group of mice. The gating strategy shows cells that were BrdU. (F) Expression of BrdU on CD4 cells in sdLN
from 1WT, 4WT, 1 IL-10 KO, and 4 IL-10 KO mice as a proportion of total CD4 cells. Symbols indicate the percent positive cells for individual mice;
horizontal bars represent means standard errors of the means (n 4 mice). (G) Proliferation of CD4 cells shown as a proportion of CFSEdim CD4 cells for
groups of 1 WT, 4 WT, 1 IL-10 KO, and 4 IL-10 KO mice. Cells were cultured in vitro in the presence or absence of SSAP. Bars show the means and
standard errors of the means (n 4). (H and I) Production of IFN- (H) and IL-4 (I) determined by cytokine-specific ELISAs. The dotted lines represent the
minimum level of detection. For all experiments, statistical significance was determined by using the Mann-Whitney U test (n.s., P
 0.05; , P	 0.05; , P	
0.01; , P	 0.001). Data are representative of results from 2 to 4 independent experiments.
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which may therefore contribute to CD4 lymphocyte hypore-
sponsiveness.
DISCUSSION
We show that after a single (1) exposure of mice to infective S.
mansoni cercariae, CD4 T cells from the sdLN proliferate vigor-
ously in vivo, or in vitro upon parasite antigen restimulation, and
that these cells secrete substantial amounts of IFN- and IL-4.
However, after repeated infections (i.e., 4), CD4 cells were not
able to proliferate or secrete cytokines in response to antigen re-
stimulation. It is possible that CD4hyporesponsiveness is caused
by exhaustion due to the presence of high levels of antigen (23)
following four exposures to infective cercariae. However, this
seems unlikely, since exposure of mice to one high-dose infection
FIG 6 CD4 cells in sdLN of 4 IL-10 KO mice have an enhanced activation status and are less prone to apoptosis. (A) Total number of viable sdLN cells in 1
WT, 4WT, 1KO, and 4KO mice. Bars show means and standard errors of the means (n 4 to 5). (B to D) Expression of CD69 (B), CD44 (C), and CD62lo
(D) on CD4 cells in sdLN from 1 and 4 WT or KO mice, expressed as a proportion of total CD4 cells from each group of mice. Symbols are percent
expression values for individual mice; horizontal bars show the means standard errors of the means (n 4 mice). (E and F) Transcript analysis by quantitative
PCR for Fas (left) and FasL (right) in mRNA from the sdLN (E) and expression of Fas (left) and FasL (right) on CD4 cells from the sdLN of 4WT and 4KO
mice, expressed as a proportion of total CD4 cells from each group of mice (F). (G) Representative flow dot plots for the sdLN of 4 WT and 4 KO mice
showing the expression of annexin V versus PI, where annexin V PI cells are apoptotic, annexin V PI are dead, and annexin V PI cells are live. (H) Total
proportions of annexin V PI, annexin V PI, and annexin V PI cells from 4WT and 4KO mice. Data from groups of mice are presented as bar charts,
with bars representing the means and standard errors of the means (n 4 mice). Statistical significance was determined by using the Mann-Whitney U test (n.s.,
not significant; , P	 0.05; , P	 0.01; , P	 0.001). Data are representative of results from 3 independent experiments.
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(600 cercariae), which is equivalent to the cumulative dose after
four infections (i.e., 4with 150 cercariae), resulted in a prolifer-
ative and cytokine response of a magnitude similar to that follow-
ing a single dose of 150 cercariae. The hyporesponsive state was
parasite antigen specific, as repeated exposure to infective para-
sites (i.e., 4 doses) did not affect the capacity of sdLN cells from
OT-II mice to proliferate, but appeared to differ from data from
previous studies of mice exposed to high antigenic loads due to
prepatent schistosome worm infections, which caused hypore-
sponsiveness to schistosome as well as nonschistosome antigens
(27).
An alternative explanation for the development of hypore-
sponsiveness is CD4 cell intrinsic anergy (21, 22), as demon-
strated in our model by the partial restoration of antigen-specific
proliferation of in vitro-cultured 4 sdLN cells in the presence of
exogenous recombinant IL-2. However, although the prolifera-
tion of 4 cells in the presence of IL-2 was significantly increased
compared to that in 4 cells stimulated with antigen only, it was
still well below the level of proliferation recorded for 1 sdLN
cells (with or without additional IL-2). In addition, while the ex-
pression levels of the anergy-related factors PD1 and PDL-1 (24,
47) on CD4 cells were higher in 4 than in 1WT mice, there
was no significant change in the expression level of PD1 in the
absence of IL-10 despite the restoration of CD4 cell responsive-
ness. Furthermore, the administration of anti-PD1 antibody in
vivo to 4 WT mice led to only a small increase in the ability of
CD4T cells to proliferate. This contrasts with data from previous
studies of parasitic helminth infections, where a blockade of PD1
during infection with Litomosoides sigmodontis led to a major res-
toration of Th2 responsiveness mediated by PDL-2 (52), or expo-
sure to adult schistosome worms (prior to the Th2-polarized
chronic phase of infection), where T cell anergy was induced via
PDL-1-mediated regulation (53). Nevertheless, taken together,
our data indicate that although anergy involving PD1 may be op-
erational in our multiple-infection model, it does not appear to
have a major role, and it is possible that other inhibitory factors
associated with hyporesponsiveness may be involved. For exam-
ple, LAG3 (54) and its expression along with CD49b have been
reported in helminth-infected mice (55), and GRAIL (gene related
to anergy in lymphocytes) has been linked to a decline in Th2 cell
responsiveness due to repeated stimulation with schistosome egg
antigens (56). Microarray analysis of CD4 T cells from 4 versus
1 mice might reveal anergy-associated genes in our model of
repeated exposure to schistosome larvae.
While the number of CD25 FoxP3 Treg cells rapidly in-
creased in other models of helminth infection (41, 57, 58), there
was no significant increase in the number of FoxP3 Treg cells as a
proportion of CD4 cells in 4 compared to 1mice, nor were
there differences in the expression levels of CD103 and CTLA-4
markers on FoxP3 Treg cells or in the abundances of thymic
Helios Nrp1 CD4 cells discrete from peripheral Treg cells.
Moreover, as there were no differences in the frequencies of con-
ventional Treg populations in the absence of IL-10, and since the
transfer of FoxP3 CD4 cells from 4 into 1 mice did not
confer hyporesponsiveness to recipient mice (data not shown), we
conclude that our data do not support a role for FoxP3 Treg cells
at this early period in the sdLN. This finding agrees with data from
a previous study of prepatent 4-week schistosome infections,
where CD4 cell hyporesponsiveness was also independent of Treg
cells (27). This is perhaps not unexpected, as it is normally thought
that Treg cells have a functional effect on the immune response to
parasitic helminths following long-term chronic infection requir-
ing the presence of persistent antigen (18), whereas in our model
of repeat infection, hyporesponsiveness was evident within the
first weeks after infection.
The major factor demonstrated to be critical for the develop-
ment of hyporesponsiveness in our model is the cytokine IL-10. It
is an important regulator of the adaptive immune response (50,
59) and has been described as a “master” of immune regulation in
the context of infectious disease (49). IL-10 could be derived from
lymphoid Th1 or Th2 cells as well as cells of myeloid origin, such
as macrophages, dendritic cells, or mast cells (30–32, 50, 51, 55).
Although we have previously shown that the level of secretion of
IL-10 following 72 h of in vitro culture of sdLN cells in response to
parasite antigen was markedly lower for 4 than for 1 cells (14),
we demonstrate here that the majority of IL-10 detected within
sdLN cells recovered directly ex vivo from 1 and 4mice, with-
out additional stimulation with antigen or PMA, is derived from
CD4 cells. However, this rare (0.25% of total sdLN cells from
4 mice) population of T cells does not proliferate or secrete
abundant cytokines in response to antigen restimulation in vitro.
While FoxP3 Tr1 cells have been identified as the main source of
CD4 cell-derived IL-10 following chronic infection with other
helminths (55, 60), they did not contribute greatly to the numbers
of IL-10/GFP cells detected ex vivo in the present study. There-
fore, we conclude that since the abundance of IL-10/GFP CD4
cells in the sdLN of 4mice was substantially increased compared
to that in 1 cohort mice, the majority of IL-10 is derived from
nonregulatory CD4 cells (i.e., non-Treg cells), which could be
Th2 effector cells, but appears to be the primary cause of early-
stage CD4 cell hyporesponsiveness in the sdLN.
When hyporesponsive CD4 cells from 4 WT mice were
cocultured with endogenous APCs from the sdLN of responsive
4 KO mice, their ability to proliferate was not restored, suggest-
ing that the hyporesponsive state is intrinsic to CD4 T cell pop-
ulations and not dependent upon the presence of extrinsic APCs.
We previously showed that dermal cells with antigen-presenting
function from the skin of mice exposed to multiple doses of infec-
tious cercariae, a site which is rich in IL-10, had an impaired ability
to support the proliferation of sdLN CD4 cells from 1 mice
(14). While this may seemingly be at odds with our current find-
ings, we do not know whether the different types of potential
APCs in the skin migrate to a site of immune priming in the sdLN
in the same, or similar, proportions as those observed in the skin.
Myeloid APCs in the skin of multiply infected mice had an M2-
like phenotype (14), but we have found no evidence for alterna-
tively activated macrophages in the sdLN after multiple infections
(data not shown). Nevertheless, in the absence of IL-10, CD4
sdLN cells from 4 KO mice have a more activated phenotype,
illustrated by increased expressions of CD69 and CD44, leading to
their enhanced ability to proliferate in vivo and in vitro and secrete
IFN- in response to antigen-specific stimulation in vitro. In this
respect, it is notable that the number of cells in the sdLN of 4KO
mice was significantly larger than that of 4WT mice, indicating
that the numbers of cells from 4 KO mice are more likely to
expand. In contrast, a higher proportion of cells from 4 WT
mice enter apoptosis and therefore are unable to respond to anti-
gen. Together, these findings show that IL-10 in 4WT mice acts
to suppress CD4 T cell proliferation and the ability of these cells
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to become activated and increases the likelihood of them entering
apoptosis, ultimately leading to cell death.
The mechanism by which IL-10 may promote apoptosis and
AICD is unclear. In vivo, IL-10 can regulate FasL expression, lead-
ing to increased T cell death (61), although others consider IL-10
to have a minimal role in driving CD4 T cell AICD (25). In our
studies of multiple schistosome infections, there was a significant
decrease in the expression level of Fas mRNA in the sdLN of 4
KO mice, and there was significantly less apoptosis and cell death
in 4 KO mice in the absence of IL-10, accompanied by an in-
crease in the number of viable cells. Evidence for a change in FasL
expression in KO mice is less convincing; consequently, another
FasL-independent mechanism (25, 62, 63) involving IL-10 may
contribute to apoptosis/cell death in our model.
In conclusion, we provide evidence for the induction of IL-10-
associated apoptosis of CD4 cells, which leads to the develop-
ment of hyporesponsiveness in the lymph nodes draining the site
of infection shortly after exposure to repeated doses of infective
schistosome parasites. This occurs prior to the downregulation of
immune responses due to schistosome eggs being released from
adult worms during chronic infection (2, 6, 20, 29) and demon-
strates that immune downregulation also operates during the
early stages of parasite development and particularly in response
to repeated exposure to infectious cercariae. The data presented
here have wider relevance to the study of immune responses to
other infectious pathogens, as most studies examine immune pro-
cesses after only a single infectious dose. Our study shows that it is
important to consider the effect of repeated/multiple exposures to
different pathogens, as this is likely to be more significant in light
of exposure to infectious agents in the natural world. While it is
probable that there are several overlapping, and possibly redun-
dant, mechanisms that underpin the development of CD4 cell
hyporesponsiveness, it is clear that IL-10 can have a central role. In
this context, IL-10 was reported to be related to the intensity of
human schistosomiasis (13, 64), which may be the cumulative
result of repeated exposure to infectious cercariae as well as eggs
released by adult worms.
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